Heim4516 • TYO
add
Nippon Shinyaku Co Ltd
Við síðustu lokun
5.096,00 ¥
Dagbil
5.081,00 ¥ - 5.166,00 ¥
Árabil
2.967,00 ¥ - 6.529,00 ¥
Markaðsvirði
361,02 ma. JPY
Meðalmagn
306,43 þ.
V/H-hlutf.
11,60
A/V-hlutfall
2,41%
Aðalkauphöll
TYO
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (JPY) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 47,49 ma. | 13,10% |
Rekstrarkostnaður | 18,06 ma. | 36,52% |
Nettótekjur | 10,08 ma. | -17,20% |
Hagnaðarhlutfall | 21,23 | -26,82% |
Hagnaður á hvern hlut | — | — |
EBITDA | 14,41 ma. | -12,27% |
Virkt skatthlutfall | 23,57% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (JPY) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 60,77 ma. | 9,65% |
Heildareignir | 328,11 ma. | 15,34% |
Heildarskuldir | 43,91 ma. | 19,73% |
Eigið fé alls | 284,20 ma. | — |
Útistandandi hlutabréf | 67,40 m. | — |
Eiginfjárgengi | 1,21 | — |
Arðsemi eigna | 10,20% | — |
Ávöxtun eigin fjár | 11,61% | — |
Peningaflæði
Breyting á handbæru fé
| (JPY) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 10,08 ma. | -17,20% |
Handbært fé frá rekstri | -1,94 ma. | -219,60% |
Reiðufé frá fjárfestingum | 775,00 m. | -59,78% |
Reiðufé frá fjármögnun | -4,35 ma. | -2,21% |
Breyting á handbæru fé | -4,52 ma. | -367,91% |
Frjálst peningaflæði | -2,12 ma. | -141,86% |
Um
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
Stofnsett
1. okt. 1919
Vefsvæði
Starfsfólk
2.243
